Skip to main content

Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma.

Publication ,  Journal Article
Ichimiya, Y; Alluri, K; Marcus, C; Best, S; Chung, CH; Subramaniam, RM
Published in: Am J Nucl Med Mol Imaging
2015

The objective of this study is to establish the utilization trends of CT, MRI, and FDG-PET/CT for evaluation of oropharyngeal squamous cell carcinoma (OPSCC) patients. A total of 173 patients with newly diagnosed stage III or IV OPSCC between 2003 and 2009 were included. Frequency of imaging modality use, divided into four time periods (2003-04, 2005-06, 2007-08 and 2009), was evaluated. For initial staging, percentage of PET/CT use was 64.6%, 87.5%, 94.1% and 96.3%, with an increasing trend (p < 0.001). The CT (p = 0.762) and MRI (p = 0.224) use demonstrated no change in trend. For post-treatment imaging, percentage of PET/CT use was 59.5%, 68.6%, 89.7% and 100%, with an increasing trend (p < 0.001). The CT use demonstrated a decreasing trend (p = 0.004) and MRI showed no trend change (p = 0.231). PET/CT is used with an increasing trend for initial staging and has become a central imaging modality for follow up evaluation after treatment, for advanced OPSCC.

Duke Scholars

Published In

Am J Nucl Med Mol Imaging

ISSN

2160-8407

Publication Date

2015

Volume

5

Issue

2

Start / End Page

154 / 161

Location

United States
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ichimiya, Y., Alluri, K., Marcus, C., Best, S., Chung, C. H., & Subramaniam, R. M. (2015). Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma. Am J Nucl Med Mol Imaging, 5(2), 154–161.
Ichimiya, Yukako, Krishna Alluri, Charles Marcus, Simon Best, Christine H. Chung, and Rathan M. Subramaniam. “Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma.Am J Nucl Med Mol Imaging 5, no. 2 (2015): 154–61.
Ichimiya Y, Alluri K, Marcus C, Best S, Chung CH, Subramaniam RM. Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma. Am J Nucl Med Mol Imaging. 2015;5(2):154–61.
Ichimiya, Yukako, et al. “Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma.Am J Nucl Med Mol Imaging, vol. 5, no. 2, 2015, pp. 154–61.
Ichimiya Y, Alluri K, Marcus C, Best S, Chung CH, Subramaniam RM. Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma. Am J Nucl Med Mol Imaging. 2015;5(2):154–161.

Published In

Am J Nucl Med Mol Imaging

ISSN

2160-8407

Publication Date

2015

Volume

5

Issue

2

Start / End Page

154 / 161

Location

United States